Published in Br J Cancer on June 01, 1990
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1975) 23.42
A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. Anal Biochem (1984) 22.53
Molecular biology of fibronectin. Annu Rev Cell Biol (1985) 3.39
Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol (1988) 1.73
Fibronectin's amino-terminal matrix assembly site is located within the 29-kDa amino-terminal domain containing five type I repeats. J Biol Chem (1988) 1.37
Genetic control of lipid transport in mice. I. Structural properties and polymorphisms of plasma lipoproteins. J Biol Chem (1983) 1.29
Fibroblasts on the move. J Cell Biol (1988) 1.26
Heparan sulfate proteoglycan from the extracellular matrix of human lung fibroblasts. Isolation, purification, and core protein characterization. J Biol Chem (1988) 1.02
Enhanced cellular fibronectin accumulation in chondrocytes treated with vitamin A. Cell (1979) 1.02
Tumour cells which develop resistance to cytolysis by tumour necrosis factor have a different glycoform of a 105-kDa glycoprotein and lose the capacity to invade and metastasize. Int J Cancer (1990) 0.94
Glycosylation-dependent collagen-binding activities of two membrane glycoproteins in MDAY-D2 tumor cells. Cancer Res (1988) 0.93
Incorporation of cellular and plasma fibronectins into smooth muscle cell extracellular matrix in vitro. Proc Natl Acad Sci U S A (1985) 0.93
Stromal fibronectin staining pattern and metastasizing ability of human breast carcinoma. Cancer Res (1988) 0.82
Altered accumulations of fibronectin are not dependent on fibronectin modifications during the differentiation of F-9 teratocarcinoma stem cells. Exp Cell Res (1988) 0.81
Asn-linked oligosaccharide processing and malignant potential. Cancer Surv (1988) 0.80
Morphological and metastatic murine melanoma variants: motility, adhesiveness, cell surface and in vivo properties. Br J Cancer (1987) 0.78
Relationship between tumour cell morphology, gap junctions and susceptibility to cytolysis by tumour necrosis factor. Br J Cancer (1989) 0.78
Distribution of plasma fibronectin in the metastatic lesion of cancer: experimental study by autoradiography. Thromb Res (1988) 0.78
Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties. Br J Cancer (1978) 3.38
Tumour-necrosis factor from the rabbit. II. Production by monocytes. Br J Cancer (1978) 2.48
Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. Clin Exp Immunol (1984) 2.34
Production of an anti-tumour cytotoxin by human monocytes. Immunology (1981) 1.78
Characterization of cytotoxic spleen cells and effects of serum factors in a syngeneic rat tumour system. Br J Cancer (1976) 1.53
Tumour-necrosis factor from the rabbit. IV. Purification and chemical characterization. Br J Cancer (1980) 1.47
Triiodothyronine in the recovery of stunned myocardium in dogs. Ann Thorac Surg (1991) 1.40
Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. Am J Med Genet (1999) 1.31
Production of an anti-tumour cytotoxin by human monocytes: comparison of endotoxin, interferons and other agents as inducers. Br J Cancer (1982) 1.28
Tumour-necrosis factor from the rabbit. III. Relationship to interferons. Br J Cancer (1979) 1.23
Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology (1993) 1.22
Agglutinins to bacteria in Crohn's disease. Gut (1980) 1.19
Involvement of phospholipase A2 activation in tumour cell killing by tumour necrosis factor. Immunology (1988) 1.17
Neutral amino acid uptake by the microvillous plasma membrane of the human placenta is inversely related to fetal size at birth in normal pregnancy. J Clin Endocrinol Metab (1998) 1.15
Tumour-necrosis factor from the rabbit. V. Synthesis in vitro by mononuclear phagocytes from various tissues of normal and BCG-injected rabbits. Br J Cancer (1981) 1.13
Inherited thrombocytopenia, elevated serum IgA and renal disease: identification as a variant of the Wiskott-Aldrich syndrome. Q J Med (1986) 1.12
Effect of human monocyte killing of tumour cells of antibody raised against an extracellular monocyte cytotoxin. Immunology (1983) 1.07
Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma. Br J Cancer (1975) 1.07
Immunogenicity of lipid-conjugated antigens. II. Anti-complementary activity and antigen trapping in the spleen. Immunology (1980) 1.04
pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells. J Biol Chem (1999) 1.01
Anti-tumour cytotoxin produced by human monocytes: studies on its mode of action. Br J Cancer (1983) 0.99
Human growth hormone in cultures of human pituitary tumors. J Neurosurg (1971) 0.97
Coeliac disease associated with auto-immune thyroiditis, Sjogren's syndrome, and a lymphocytotoxic serum factor. Aust N Z J Med (1972) 0.97
A case of hereditary combined deficiency of complement components C6 and C7 in man. Clin Exp Immunol (1989) 0.97
A study of cell mediated and humoral immunity in haemophilia and related disorders. Br J Haematol (1985) 0.97
Smoking, humoral immunity, and ulcerative colitis. Gut (1991) 0.95
Tumour necrosis factor activity in joint fluids from rheumatoid arthritis patients. Br J Rheumatol (1989) 0.95
Zymosan-induced leukotriene B4 generation by human neutrophils is augmented by rhTNF-alpha but not chemotactic peptide. Immunology (1990) 0.94
Recurrent meningococcal infections associated with a functional deficiency of the C8 component of human complement. Clin Exp Immunol (1980) 0.94
Tumour cells which develop resistance to cytolysis by tumour necrosis factor have a different glycoform of a 105-kDa glycoprotein and lose the capacity to invade and metastasize. Int J Cancer (1990) 0.94
Lymphoid cell fractionation by aggregated immunoglobulin-agarose columns. J Immunol Methods (1976) 0.94
Autoimmunity to collagen in adult periodontal disease: immunoglobulin classes in sera and tissue. J Periodontal Res (1992) 0.90
Fetuin: an acute phase protein in cattle. J Comp Physiol B (1992) 0.90
"Spontaneous" cytolysis by normal human lymphocytes of Burkitt's lymphoma cells of the EB2 cell line. Aust J Exp Biol Med Sci (1974) 0.90
Human monocyte killing of tumor cells: contribution of an extracellular cytotoxin. Adv Exp Med Biol (1982) 0.88
Effect of serine/threonine kinase inhibitors on motility of human lymphocytes and U937 cells. Immunology (1994) 0.88
Antibodies to influenza A in a cluster of children with juvenile chronic arthritis. Br J Rheumatol (1988) 0.88
Production of hemopoietic growth factors and gamma-interferon by large granular lymphocytes from patients with T gamma lymphocytosis. Int J Cell Cloning (1987) 0.88
A simple, sensitive and reproducible assay for pyridoxal 5'-phosphate and 4-pyridoxic acid in human plasma. Clin Chim Acta (1999) 0.87
Cardiovascular and pulmonary function studies of a new sedative/analgetic (detomidine/Domosedan) for use alone in horses or as a preanesthetic. Acta Vet Scand Suppl (1986) 0.87
Characterisation of a new tryptic sub-fragment of human and rabbit IgG Fc fragment. Immunochemistry (1971) 0.86
Inhibition of protein kinase C results in a switch from a non-motile to a motile phenotype in diverse human lymphocyte populations. Immunology (1995) 0.85
Differential augmentation by recombinant human tumor necrosis factor-alpha of neutrophil responses to particulate zymosan and glucan. J Immunol (1990) 0.85
Chemical synthesis, expression and product assessment of a gene coding for biologically active human tumour necrosis factor alpha. Protein Eng (1989) 0.85
Active systemic lupus erythematosus is associated with the recruitment of naive/resting T cells. Br J Rheumatol (1996) 0.84
Tumour necrosis factor induction of ELAM-1 and ICAM-1 on human umbilical vein endothelial cells--analysis of tumour necrosis factor-receptor interactions. Cytokine (1992) 0.84
Chlamydia and Crohn's disease. Lancet (1979) 0.83
alpha 2HS-glycoprotein is expressed at high concentration in human fetal plasma and cerebrospinal fluid. Fetal Diagn Ther (1993) 0.82
Guillain-Barré syndrome associated with Campylobacter enteritis in a child. J Pediatr (1986) 0.81
Measurement of antibodies to Candida albicans as a screening test for humoral immunodeficiency. J Immunol Methods (1987) 0.81
Motion rivalry impairs motion repulsion. Vision Res (2001) 0.81
Serum antibodies to anaerobic coccoid rods in patients with Crohn's disease or ulcerative colitis, and in medical and nursing staff. Br Med J (Clin Res Ed) (1981) 0.81
Antibody response to anaerobic coccoid rods in Crohn's disease. J Clin Pathol (1986) 0.80
Human monocyte cytotoxin is not identical with lymphoblastoid lymphotoxin. Eur J Immunol (1985) 0.80
Cardiopulmonary bypass and complement activation. Involvement of classical and alternative pathways. Anaesthesia (1982) 0.80
Nitric oxide is produced during TNF killing of U937A cells but does not contribute to the cytotoxic process. Biochim Biophys Acta (1993) 0.79
Human neutrophil responses to pathogenic Escherichia coli are receptor-specific and selectively augmented by recombinant human tumor necrosis factor-alpha. J Infect Dis (1991) 0.79
A simple multistage field test for the prediction of anaerobic capacity in female games players. Br J Sports Med (2004) 0.79
Characterization of the normal lymphocyte population cytolytic to Burkitt's lymphoma cells of the EB2 cell line. Aust J Exp Biol Med Sci (1976) 0.79
Protein kinase C isotype expression and regulation of lymphoid cell motility. Immunology (1996) 0.79
Inducibility of class II major histocompatibility complex antigens by interferon gamma is associated with reduced tumorigenicity in C3H mouse fibroblasts transformed by v-Ki-ras. J Exp Med (1991) 0.78
Agglutinins to anaerobic bacteria in Crohn's disease and in Indian patients with diarrhoea. J Med Microbiol (1984) 0.78
Anti-tumour cytotoxin from macrophages: no correlation between cytotoxin adsorption by tumour cell lines and their cytotoxin susceptibility. Immunology (1984) 0.78
Synthesis of the foetal protein fetuin by early developing neurons in the immature neocortex. J Neurocytol (1993) 0.78
The selective augmentation by recombinant human tumour necrosis factor-alpha of neutrophil responses to pathogenic Escherichia coli. Immunology (1990) 0.77
Photographic and spectroscopic correlations of human cataracts. Ophthalmic Res (1989) 0.77
Recurrent cerebral metastasis from a cardiac myxoma: case report and review of literature. Br J Neurosurg (2006) 0.77
Reduced levels of alpha-1-antitrypsin in children exposed to high levels of air pollution. Biol Neonate (1993) 0.77
Use of the defined antigen substrate spheres system as a model for analysing possible mechanisms of inhibition-blockade of anti-tumour lymphocytotoxicity. Immunology (1975) 0.75
Characterization of serum factors modulating splenic cytotoxicity in a syngeneic rat tumour system. Br J Cancer (1976) 0.75
Zn-binding globulin in human fetal brain and liver: a marker for passive blood/CSF transfer of protein. Neuropathol Appl Neurobiol (1993) 0.75
Insertion of neonatal intercostal catheters. Crit Care Resusc (2003) 0.75
Inhibition of K cell function by human breast cancer sera. Br J Cancer (1976) 0.75
Meningococcal infection and proteolytic control. J Clin Pathol (1978) 0.75
Antimicrobial properties of preterm breast milk cells. Arch Dis Child (1983) 0.75
Bacterial identification using nitrocellulose blotting technique that incorporates ELISA to bacterial surface antigen. J Clin Pathol (1987) 0.75
Glued to the bedside: staff veterans. Interview by Barbara Barzoloski-O'Connor. Nurs Spectr (Wash D C) (1995) 0.75
Assessing a pregnant woman after trauma. Nursing (1990) 0.75
Extremely low phase noise UHF oscillators utilizing high-overtone, bulk-acoustic resonators. IEEE Trans Ultrason Ferroelectr Freq Control (1992) 0.75
Development of tumor cell resistance to tumor necrosis factor cytolysis results in reduced fibronectin binding and altered ganglioside expression. Cytokine (1991) 0.75
Bioequivalence of an ezetimibe/simvastatin combination tablet and coadministration of ezetimibe and simvastatin as separate tablets in healthy subjects. Int J Clin Pharmacol Ther (2006) 0.75
Letter: Spontaneous cytotoxic-activity as a test of human lymphocyte function. Lancet (1975) 0.75
Immunofluorescence in cancer investigation and research. Ann N Y Acad Sci (1975) 0.75
Serum and salivary immunoglobulin A and free secretory component in ulcerative colitis. Clin Allergy (1981) 0.75
Continuous veno-venous hemodiafiltration using bicarbonate dialysate. Pediatr Nephrol (1997) 0.75
Mixed lymphocyte reaction supernatants exert varied effects upon gingival fibroblasts in vitro. J Clin Lab Immunol (1985) 0.75
Antimicrobial effects of a macrophage-derived cytotoxin from the serum of BCG-primed rabbits (tumour necrosis serum). J Med Microbiol (1984) 0.75
Convulsions after miconazole overdose. Med J Aust (1987) 0.75
Development of tumour cell resistance to tumour necrosis factor does not confer resistance to cytotoxic drugs. Eur J Cancer Clin Oncol (1989) 0.75
Buccal biopsy in diagnosis of Crohn's disease. Lancet (1979) 0.75
Meningococcal endocarditis with profound acquired hypocomplementaemia. J Infect (1985) 0.75
[Not Available]. Immunol Today (1984) 0.75